Preview

Rational Pharmacotherapy in Cardiology

Advanced search

HYPERMOBILITY SYNDROME: CLINICAL MANIFESTATIONS, DIFFERENTIAL DIAGNOSIS, THERAPY APPROACHES

https://doi.org/10.20996/1819-6446-2008-4-3-72-75

Full Text:

Abstract

Connective tissue dysplasia (CTD) represents special ontogenetic abnormality which is a complex problem of contemporary medicine. The principles of differential diagnosis of various forms of CTD are considered. A clinical estimation and therapy approaches are discussed with focus on hypermobility syndrome as one of undifferentiated form of CTD.

About the Authors

N. A. Shostak
Russian State Medical University, Moscow
Russian Federation
Chair of Faculty Therapy named after A.I. Nesterov


N. G. Pravdyuk
Russian State Medical University, Moscow
Russian Federation
Chair of Faculty Therapy named after A.I. Nesterov


References

1. Sillence D.O., Rimoin D.L. Classification of osteogenesis imperfect. Lancet 1978;1(8072):1041–2.

2. Яковлев В.М., Нечаева Г.И. Кардио-респираторные синдромы при дисплазии соединительной ткани. Омск: Издательство ОГМА; 1994.

3. Grahame R. Joint hypermobility and genetic collagen disorders: are they related? Arch Dis Child 1999; 80(2):188–91.

4. Kirk J.A., Ansell B.M., Bywaters E.G. The hypermobility syndrome. Musculoskeletal complaints associated with generalized joint hypermobility. Ann Rheum Dis 1967;26(5):419–25.

5. Grahame R., Bird H.A., Child A. The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). J Rheumatol 2000;27(7): 1777–9.

6. Беленький А.Г. Генерализованная гипермобильность суставов и другие соединительно–тканные синдромы. Научно–практическая ревматология 2001;(4):40–8.

7. Zweers M.C., Bristow J., Steijlen P.M. et al. Haploinsufficiency of TNXB is associated with hypermobility type of Ehlers-Danlos syndrome. Am J Hum Genet 2003; 73(1):214–17.

8. Кадурина Т.И. Наследственные коллагенопатии (клиника, диагностика, лечение и диспансеризация). СПб.: Невский диалект; 2000.

9. Beighton P., De Paepe A., Steinmann B. et al. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet 1998;77(1): 31–7.

10. Simpson M.R. Benign joint hypermobility syndrome: evaluation, diagnosis, and management. J Am Osteopath Assoc 2006; 106(9): 531-6.

11. De Paepe A., Devereux R.B., Dietz H.C. et al. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996;62(4):417–26.

12. Громова О.А., Торшин И.Ю. Дисплазия соединительной ткани, клеточная биология и молекулярные механизмы воздействия магния. РМЖ 2008;16(4):230-8.

13. Пак Л.С. Значение магния в патогенезе и лечении больных пролапсом митрального клапана. Трудный пациент 2007;5(5):13-6.


For citation:


Shostak N.A., Pravdyuk N.G. HYPERMOBILITY SYNDROME: CLINICAL MANIFESTATIONS, DIFFERENTIAL DIAGNOSIS, THERAPY APPROACHES. Rational Pharmacotherapy in Cardiology. 2008;4(3):72-75. (In Russ.) https://doi.org/10.20996/1819-6446-2008-4-3-72-75

Views: 372


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)